Medical research (or biomedical research ), also known as health research , refers to the process of using scientific methods with the aim to produce knowledge about human diseases, the prevention and treatment of illness, and the promotion of health.
91-582: The Baker Heart and Diabetes Institute , commonly known as the Baker Institute , is an Australian independent medical research institute headquartered in Melbourne , Victoria . Established in 1926, the institute is one of Australia's oldest medical research organisations with a historical focus on cardiovascular disease . In 2008, it became the country's first medical research institute to target diabetes , heart disease , obesity and their complications at
182-409: A preclinical understanding – to clinical research , which involves studies of people who may be subjects in clinical trials . Within this spectrum is applied research , or translational research , conducted to expand knowledge in the field of medicine . Both clinical and preclinical research phases exist in the pharmaceutical industry 's drug development pipelines, where the clinical phase
273-425: A 7.8% increase (adjusted for inflation). In 2007 the most heavily funded institutions received 20% of HIN medical research funding, and the top 50 institutions received 58% of NIH medical research funding, the percent of funding allocated to the largest institutions is a trend which has increased only slightly over data from 1994. Relative to federal and private funding, health policy and service research accounted for
364-565: A US regulatory standpoint where great investment has been made in research ethics and standards, yet trial results remain inconsistent. Federal agencies have called upon greater regulation to address these problems; a spokesman from the National Institute of Neurological Disorders and Stroke, an agency of the NIH, stated that there is "widespread poor reporting of experimental design in articles and grant applications, that animal research should follow
455-436: A biochemist. Corkill described the methods of diagnosis and treatment of diabetes mellitus at The Alfred Hospital in 1927. Twenty years later, in 1947, a young biochemist called Joe Bornstein was introduced to Corkill. Their work together resulted in the discovery of the two forms of diabetes—insulin dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes mellitus (NIDDM). This discovery in 1949 "... literally changed
546-699: A cardiac physiologist noted for his contributions to the understanding of hypertension, took on the role of director in 1975 and by this time, the sole focus of the institute was cardiovascular disease research. Significant advancements during this time included new strategies for hypertension; greater understanding of the role of the autonomic nervous system; insight into the role of cholesterol in atherogenesis and triglycerides as an independent risk factor for coronary atherosclerosis. Notable investigators included Paul Nestel (nutrition, CVD, atherosclerosis and lipid metabolism), Murray Esler (causes and treatment of high blood pressure and heart failure, and effects of stress on
637-434: A climate of secrecy and self-protection, stifling creativity and collaboration. The power imbalance in academic hierarchies exacerbates these issues, with junior researchers often subjected to exploitative practices and denied proper recognition for their contributions. After clinical research, medical therapies are typically commercialized by private companies such as pharmaceutical companies or medical device company. In
728-506: A clinical trial, members of the public can actively collaborate with researchers in designing and conducting medical research. This is known as patient and public involvement (PPI). Public involvement involves a working partnership between patients, caregivers, people with lived experience, and researchers to shape and influence what is researcher and how. PPI can improve the quality of research and make it more relevant and accessible. People with current or past experience of illness can provide
819-692: A conflict of interest in the field of biomedical research. Survey results from one study concluded that 43% of scientific investigators employed by a participating academic institution had received research related gifts and discretionary funds from industry sponsors. Another participating institution surveyed showed that 7.6% of investigators were financially tied to research sponsors, including paid speaking engagements (34%), consulting arrangements (33%), advisory board positions (32%) and equity (14%). A 1994 study concluded that 58% out of 210 life science companies indicated that investigators were required to withhold information pertaining to their research as to extend
910-616: A core set of research parameters, and that a concerted effort by all stakeholders is needed to disseminate best reporting practices and put them into practice". Medical research is highly regulated. National regulatory authorities are appointed in most countries to oversee and monitor medical research, such as for the development and distribution of new drugs. In the United States, the Food and Drug Administration oversees new drug development; in Europe,
1001-454: A decline in the share of key research grants going to younger scientists, as well as a steady rise in the age at which investigators receive their first funding. A significant flaw in biomedical research is the toxic culture that particularly impacts medical students and early career researchers. They face challenges such as bullying, harassment, and unethical authorship practices. Intense competition for funding and publication pressures fosters
SECTION 10
#17331155969081092-430: A different perspective than professionals and complement their knowledge. Through their personal knowledge they can identify research topics that are relevant and important to those living with an illness or using a service. They can also help to make the research more grounded in the needs of the specific communities they are part of. Public contributors can also ensure that the research is presented in plain language that
1183-407: A doubling of NIH funding, spurring an era of great scientific progress. There have been dramatic changes in the era since the turn of the 21st century to date; roughly around the start of the century, the cost of trials dramatically increased while the rate of scientific discoveries did not keep pace. Biomedical research spending increased substantially faster than GDP growth over the past decade in
1274-402: A drug is brought to the market. The Kefauver-Harris amendments were met with opposition from industry due to the requirement of lengthier clinical trial periods that would lessen the period of time in which the investor is able to see return on their money. In the pharmaceutical industry patents are typically granted for a 20-year period of time, and most patent applications are submitted during
1365-488: A host of maladies, medication for high blood pressure , improved treatments for AIDS , statins and other treatments for atherosclerosis , new surgical techniques such as microsurgery , and increasingly successful treatments for cancer . New, beneficial tests and treatments are expected as a result of the Human Genome Project . Many challenges remain, however, including the appearance of antibiotic resistance and
1456-464: A limited number of competitors. Another visible shift during the era was a shift in focus to late stage research trials; formerly dispersed, since 1994 an increasingly large portion of industry-sponsored research was late phase trials rather than early-experimental phases now accounting for the majority of industry sponsored research. This shift is attributable to a lower risk investment and a shorter development to market schedule. The low risk preference
1547-458: A nominal amount of sponsored research; health policy and service research was funded $ 1.8 billion in 2003, which increased to $ 2.2 billion in 2008. Stagnant rates of investment from the US government over the past decade may be in part attributable to challenges that plague the field. To date, only two-thirds of published drug trial findings have results that can be re-produced, which raises concerns from
1638-608: A primary interest (such as a person's welfare or the validity of research) tends to be unduly influenced by a secondary interest (such as financial gain)." Regulation on industry funded biomedical research has seen great changes since Samuel Hopkins Adams declaration. In 1906 congress passed the Pure Food and Drugs Act of 1906. In 1912 Congress passed the Shirley Amendment to prohibit the wide dissemination of false information on pharmaceuticals. The Food and Drug Administration
1729-401: A stark contrast in federal investment, from 1994 to 2003, federal funding increased 100% (adjusted for inflation). The NIH manages the majority, over 85%, of federal biomedical research expenditures. NIH support for biomedical research decreased from $ 31.8 billion in 2003, to $ 29.0 billion in 2007, a 25% decline (in real terms adjusted for inflation), while non-NIH federal funding allowed for
1820-798: A stark contrast to 25% increase in recent years. Of industry sponsored research, pharmaceutical firm spending was the greatest contributor from all industry sponsored biomedical research spending, but only increased 15% (adjusted for inflation) from 2003 to 2007, while device and biotechnology firms accounted for the majority of the spending. The stock performance, a measure that can be an indication of future firm growth or technological direction, has substantially increased for both predominantly medical device and biotechnology producers. Contributing factors to this growth are thought to be less rigorous FDA approval requirements for devices as opposed to drugs, lower cost of trials, lower pricing and profitability of products and predictable influence of new technology due to
1911-755: Is a clinical cardiologist and medical scientist, based at the Baker Heart and Diabetes Institute and the Alfred Hospital in Melbourne , where he is the Associate Director of the Heart Centre. He is a Professor of Medicine at Melbourne's Monash University . As Associate Director of the Baker, Professor Esler leads the Institute’s research into the relationship between the brain and heart health. He studied medicine at
SECTION 20
#17331155969082002-521: Is also a partner of Monash Partners Academic Health Science Centre, an Australian health industry, research and educational collaboration. In March 2015, Monash Partners was recognised by the National Health and Medical Research Council as one of four Advanced Health Research and Translation Centres in Australia. Baker Institute's longest partnership has been with The Alfred Hospital, which dates back to
2093-435: Is also reflected in the trend of large pharmaceutical firms acquiring smaller companies that hold patents to newly developed drug or device discoveries which have not yet passed federal regulation (large companies are mitigating their risk by purchasing technology created by smaller companies in early-phase high-risk studies). Medical research support from universities increased from $ 22 billion in 2003 to $ 27.7 billion in 2007,
2184-520: Is clear to the wider society and the specific groups it is most relevant for. Research funding in many countries derives from research bodies and private organizations which distribute money for equipment, salaries, and research expenses. United States, Europe, Asia, Canada, and Australia combined spent $ 265.0 billion in 2011, which reflected growth of 3.5% annually from $ 208.8 billion in 2004. The United States contributed 49% of governmental funding from these regions in 2011 compared to 57% in 2004. In
2275-559: Is denoted by the term clinical trial . However, only part of the clinical or preclinical research is oriented towards a specific pharmaceutical purpose. The need for fundamental and mechanism-based understanding, diagnostics , medical devices , and non-pharmaceutical therapies means that pharmaceutical research is only a small part of medical research. Most of the research in the field is pursued by biomedical scientists , but significant contributions are made by other type of biologists . Medical research on humans has to strictly follow
2366-544: Is funded by industry can be considered valid after a 2003 publication of "Scope and Impact of Financial Conflicts of Interest in Biomedical Research" in The Journal of American Association of Medicine. This publication included 37 different studies that met specific criteria to determine whether or not an academic institution or scientific investigator funded by industry had engaged in behavior that could be deduced to be
2457-464: Is funded from a diverse range of Government and private sources including the corporate sector, trusts and foundations and individual donors. Financial supporters from the pharmaceutical industry since 2016 include Abbott Laboratories , Amgen , AstraZeneca , Bayer , Boehringer Ingelheim , Eli Lilly and Company , GlaxoSmithKline , Merck & Co. , Novo Nordisk , Pfizer and Sanofi . The United States government has also provided funding through
2548-482: Is led by senior Institute scientists. The Institute's domains provide the management structure for the Institute and bring researchers of kindred skills together. The Baker Medical Research Institute was the creation of Dr. John F. Mackeddie, a clinical doctor and researcher, who had the idea of improving the laboratory facilities at The Alfred Hospital to keep up with advances in research. Mackeddie persuaded his friend,
2639-483: Is managed and made publicly available on usaspending.gov. Aside from the main source, usaspending.gov, other reporting mechanisms exist: Data specifically on biomedical research funding from federal sources is made publicly available by the National Health Expenditure Accounts (NHEA), data on health services research, approximately 0.1% of federal funding on biomedical research, is available through
2730-403: Is that of which industry is the financier for academic institutions which in turn employ scientific investigators to conduct research. A fear that exists wherein a project is funded by industry is that firms might negate informing the public of negative effects to better promote their product. A list of studies shows that public fear of the conflicts of interest that exist when biomedical research
2821-597: The Bill and Melinda Gates Foundation , contributed about 3% of the funding. These funders are attempting to maximize their return on investment in public health . One method proposed to maximize the return on investment in medicine is to fund the development of open source hardware for medical research and treatment. The enactment of orphan drug legislation in some countries has increased funding available to develop drugs meant to treat rare conditions, resulting in breakthroughs that previously were uneconomical to pursue. Since
Baker Heart and Diabetes Institute - Misplaced Pages Continue
2912-780: The Centers for Disease Control and Prevention and National Institutes of Health . In 2007 the Baker IDI Concise Financial Report showed receipts from granting bodies of $ 32.6 million. A further $ 7.4 million came from donations and bequests and $ 20.27 million from commercial income. The institute was a founding partner of the Alfred Medical Research and Education Precinct in 2002, which also includes Alfred Health, Monash University , Burnet Institute , La Trobe University and Deakin University . The Baker Institute
3003-654: The European Medicines Agency (see also EudraLex ); and in Japan , the Ministry of Health, Labour and Welfare . The World Medical Association develops the ethical standards for medical professionals involved in medical research. The most fundamental of them is the Declaration of Helsinki . The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) works on
3094-681: The United Kingdom , funding bodies such as the National Institute for Health and Care Research (NIHR) and the Medical Research Council derive their assets from UK tax payers, and distribute revenues to institutions by competitive research grants . The Wellcome Trust is the UK's largest non-governmental source of funds for biomedical research and provides over £600 million per year in grants to scientists and funds for research centres. In
3185-539: The University of Melbourne and received a PhD from the Australian National University (Department of Clinical Science). His chief research interests are the causes and treatment of high blood pressure and heart failure, the effects of stress on the cardiovascular system, and monoamine transmitters of the human brain. His research on the sympathetic nerves of the kidneys in essential hypertension provided
3276-482: The medical ethics sanctioned in the Declaration of Helsinki and the institutional review board where the research is conducted. In all cases, research ethics are expected. The increased longevity of humans over the past century can be significantly attributed to advances resulting from medical research. Among the major benefits of medical research have been vaccines for measles and polio , insulin treatment for diabetes , classes of antibiotics for treating
3367-499: The obesity epidemic . Example areas in basic medical research include: cellular and molecular biology , medical genetics , immunology , neuroscience , and psychology . Researchers, mainly in universities or government-funded research institutes, aim to establish an understanding of the cellular, molecular and physiological mechanisms of human health and disease. Pre-clinical research covers understanding of mechanisms that may lead to clinical research with people. Typically,
3458-547: The 20 years from 1925 was carried out at the Baker Institute in Melbourne. The initial project dealt with new techniques for diagnosing diseases of the nervous system, in particular, the changes in cell content and chemistry of cerebro-spinal fluid in various diseases. Other projects in the early days involved bacteriology , at the time the institute was started, the advancing edge of scientific medicine, and its application to
3549-489: The Alfred Hospital. In the 1950s Tom Lowe decided to make a study of congestive heart failure. He concluded "that the body's fluid system was an 'open system' with an intake and output and divisions of the contents under control of various factors". He was also interested in electrocardiography , especially vector cardiography and had machines constructed to show the three-dimensional view. Between 1949 and 1974, staff at
3640-499: The Baker Medical Research Institute also devoted a significant amount of time and energy to equipment construction to meet the needs of their researchers, this included some early, crude versions of heart-lung machines to aid in cardiac surgery. Some research on the alimentary canal also was undertaken, however this work ceased in 1968. In 1949, cardiovascular research was one of the major growth edges of medicine
3731-803: The Coalition of Health Services Research, the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, and the Veterans Health Administration. Currently, there are not any funding reporting requirements for industry sponsored research, but there has been voluntary movement toward this goal. In 2014, major pharmaceutical stakeholders such as Roche and Johnson and Johnson have made financial information publicly available and Pharmaceutical Research and Manufacturers of America (PhRMA),
Baker Heart and Diabetes Institute - Misplaced Pages Continue
3822-924: The Epidemiology of Diabetes Mellitus and Health Promotion for NCD Control). In 2017 the Baker Institute streamlined their name and became the Baker Heart and Diabetes Institute. Research, education to the public, health professionals, biomedical research students and patient care are located within the Alfred Medical Research and Education Precinct in Melbourne and Adelaide and the Baker IDI Centre for Indigenous Vascular and Diabetes Research in Alice Springs. International projects in heart disease and diabetes are currently conducted in Mauritius , South Africa , Fiji , India and Vietnam . The Baker Heart Research Institute
3913-564: The FDA remained stagnant over the same time span. Financial projections indicate federal spending will remain constant in the near future. The National Institutes of Health (NIH) is the agency that is responsible for management of the lion's share of federal funding of biomedical research. It funds over 280 areas directly related to health. Over the past century there were two notable periods of NIH support. From 1995 to 1996 funding increased from $ 8.877 billion to $ 9.366 billion, years which represented
4004-1073: The IDI operated diabetes clinics in Melbourne from the site of the Caulfield Hospital. The diabetes clinics are the largest in Victoria, with more than 8000 patients per year and continue to be operated by Baker IDI from the organisation's site in Prahran in Melbourne's inner south-east. In 2008 the Baker Heart Research Institute, as it was then known, merged with the International Diabetes Institute which had operated in Melbourne for over 25 years. Baker IDI Heart and Diabetes Institute houses World Health Organization Collaborating Centres for Research & Training in Cardiovascular Disease and Diabetes (WHO Collaborating Centre for
4095-490: The Institute's newly acquired Cambridge electrocardiograph, alongside her research into eclampsia . Dr. William J. Penfold, who was internationally renowned in bacteriology and preventative medicine and was prominent in establishing the Australian Medical Research Council, was the first director of the Baker from 1926 until 1938. He was followed by Dr. Arthur B. Corkill, who first came to the Institute as
4186-588: The International Diabetes Institute has been the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). In 2000 it was the first national study to provide estimates of the number of people with diabetes (based on blood tests) and its public health and societal impact. It is now considered an integral component of the National Diabetes Strategy to tackle the mounting problem of diabetes and its complications in Australia. In addition to research,
4277-400: The US has seen great movement over the years. The 1980 Bayh–Dole Act was passed by Congress to foster a more constructive relationship between the collaboration of government and industry funded biomedical research. The Bayh Doyle Act gave private corporations the option of applying for government funded grants for biomedical research which in turn allowed the private corporations to license
4368-430: The US, between the years of 2003 and 2007 spending increased 14% per year, while GDP growth increased 1% over the same period (both measures adjusted for inflation). Industry, not-for-profit entities, state and federal funding spending combined accounted for an increase in funding from $ 75.5 billion in 2003 to $ 101.1 billion in 2007. Due to the immediacy of federal financing priorities and stagnant corporate spending during
4459-676: The United States, data from ongoing surveys by the National Science Foundation (NSF) show that federal agencies provided only 44% of the $ 86 billion spent on basic research in 2015. The National Institutes of Health and pharmaceutical companies collectively contribute $ 26.4 billion and $ 27 billion, which constitute 28% and 29% of the total, respectively. Other significant contributors include biotechnology companies ($ 17.9 billion, 19% of total), medical device companies ($ 9.2 billion, 10% of total), other federal sources, and state and local governments. Foundations and charities, led by
4550-533: The United States, one estimate found that in 2011, one-third of Medicare physician and outpatient hospital spending was on new technologies unavailable in the prior decade. Medical therapies are constantly being researched, so the difference between a therapy which is investigational versus standard of care is not always clear, particularly given cost-effectiveness considerations. Payers have utilization management clinical guidelines which do not pay for "experimental or investigational" therapies, or may require that
4641-562: The University of Melbourne, a PhD from the University of Louvain and an MPH from Harvard School of Public Health. He has previously held the role of Head of the Cardiovascular Imaging, Heart and Vascular Institute and Imaging Institute at the Cleveland Clinic. In May 2023, the Baker Institute appointed respected cardiovascular researcher and cardiologist Professor John Greenwood MBChB, PhD as their new Director. Professor Greenwood
SECTION 50
#17331155969084732-625: The basic, clinical and population health levels. The Institute is located adjacent to The Alfred Hospital within the Alfred Research Alliance Precinct. The Baker Institute's work ranges from cellular and molecular biology research in the laboratory to clinical-based research through to lifestyle and behavioural research that aims to inform prevention strategies. The Institute has identified key areas of strength to enable scientists to channel their talents and energy in answering big-picture questions. Each of these Research Programs
4823-532: The cardiovascular system) and Garry Jennings (causes, prevention and treatment of CVD, and relationship between exercise, blood pressure, sympathetic nervous system activity and glucose metabolism). Other notable investigators whose work would come to have a significant bearing on the Institute included Paul Zimmet, who pioneered Australia's first institute dedicated exclusively to diabetes. His research in Australian, Pacific, and Indian Ocean populations has highlighted
4914-400: The concepts, research and treatment of diabetes". In the circumstances of the formation of the Institute it was to be expected that much of the research, at least in the earlier years, would be directed to the application of existing knowledge to the practical problems of clinical medicine. In their collection of memoirs of Baker Medical Research Institute Alumni, Andrew and Barnett describe
5005-625: The concepts, research and treatment of diabetes". From 1949 until 1974, Dr. Thomas E. Lowe was the institute's director. With a team of notable investigators, Lowe developed the Baker into a major research organisation with world-class facilities. The team included: It was during this time that cardiovascular research became the major focus. Research included the further development of cardiovascular surgery; new techniques of ECG and phonocardiography; treatment of congestive cardiac failure and of arterial hypertension. Sir James Officer Brown researched and tested open heart surgery in pre-clinical trials with
5096-402: The creation of rules and guidelines for the development of new medication, such as the guidelines for Good Clinical Practice (GCP). All ideas of regulation are based on a country's ethical standards code. This is why treatment of a particular disease in one country may not be allowed, but is in another. A major flaw and vulnerability in biomedical research appears to be the hypercompetition for
5187-660: The discovery of Factor V. He went on to become a member of the International Committee for the Standardisation of the Nomenclature of Blood Clotting Factors in 1956. In 1963 he was honoured when the Fantl-Koller Schema was declared. Other areas of research up to 1949 included asthma , eye disease , immunoproteins , scleroderma and surgery. The research on surgery lead to the development of cardiac surgery at
5278-480: The early stages of the product development. According to Ariel Katz on average after a patent application is submitted it takes an additional 8 years before the FDA approves a drug for marketing. As such this would leave a company with only 12 years to market the drug to see a return on their investments. After a sharp decline of new drugs entering the US market following the 1962 Kefauver-Harris amendments economist Sam Petlzman concluded that cost of loss of innovation
5369-484: The establishment of the National Institutes of Health (NIH) in the mid-1940s, the main source of U.S. federal support of biomedical research, investment priorities and levels of funding have fluctuated. From 1995 to 2010, NIH support of biomedical research increased from 11 billion to 27 billion Despite the jump in federal spending, advancements measured by citations to publications and the number of drugs passed by
5460-418: The first time reporting regulations that were previously not required. The 2006 Federal Funding Accountability and Transparency Act mandates that all entities receiving over $ 25,000 in federal funds must report annual spending reports, including disclosure of executive salaries. The 2010 amendment to the act mandates that progress reports be submitted along with financial reporting. Data from the federal mandate
5551-587: The genetic contribution of NIDDM as well as the role of obesity, physical activity, nutrition and sociocultural change in the aetiology of this disorder". In 1980 Zimmet was asked by the Council of the Australian Diabetes Society to prepare a submission, along with colleague Dr Ian Martin, titled 'Diabetes in Australia'. The submission was to the Federal Minister of Health. The submission highlighted
SECTION 60
#17331155969085642-422: The impact of diabetes in the community and what government needed to invest to find a cure or treatment and to support people with diabetes. At the same time, with Drv Matthew Cohen, Zimmet was the first to report their experience with home glucose monitoring and its acceptance in the diabetic population. They found better control, less hypoglycaemia and 95% acceptance. One of the most significant contributions of
5733-568: The institute's inception in 1926 on the hospital site. One of the significant developments of this partnership has been the Alfred Baker Medical Unit, which was established in 1949 and is the hub of joint research and clinical activity between the two institutions. Medical research Medical research encompasses a wide array of research, extending from " basic research " (also called bench science or bench research ), – involving fundamental scientific principles that may apply to
5824-459: The life of the interested companies' patents. Rules and regulations regarding conflict of interest disclosures are being studied by experts in the biomedical research field to eliminate conflicts of interest that could possibly affect the outcomes of biomedical research. Two laws which are both still in effect, one passed in 2006 and the other in 2010, were instrumental in defining funding reporting standards for biomedical research, and defining for
5915-408: The maintenance of government financial support levels through the era (the 0.7% four-year increase). Spending from industry-initiated research increased 25% (adjusted for inflation) over the same time period of time, from 2003 to 2007, an increase from $ 40 billion in 2003, to $ 58.6 billion in 2007. Industry sourced expenditures from 1994 to 2003 showed industry sponsored research funding increased 8.1%,
6006-436: The management of infectious disease in man. In the 1930s microbiology was a focus, with many of those projects reliant upon blood cultures and the techniques developed were published in a monograph – "Blood Cultures and their Significance" by H Butler in 1937. The Monograph Series lasted until 1974 – with 9 published. They covered anaesthesia , tumours , the cardiovascular system and scleroderma . Basil Corkill described
6097-452: The methods of diagnosis and treatment of diabetes mellitus at the Alfred Hospital in 1927. Twenty years later, in 1947, Joe Bornstein a young biochemist was introduced to Basil Corkill, who by then was Director of the Baker Institute. Their work together resulted in the discovery of the 2 forms of diabetes – insulin dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes mellitus (NIDDM). This discovery in 1949 “..literally changed
6188-471: The most prominent professional association for biomedical research companies, has recently begun to provide limited public funding reports. The earliest narrative describing a medical trial is found in the Book of Daniel , which says that Babylonian king Nebuchadnezzar ordered youths of royal blood to eat only red meat and wine for three years, while another group of youths ate only beans and water. The experiment
6279-439: The new insulin treatment of diabetes mellitus. In 1940, Paul Fantl became interested in blood clotting . At the time, synthetic Vitamin K was being produced and was often in short supply. Using very simple equipment – test tubes, water bath, stop watches and a centrifuge – he was "in the forefront of a revolutionary concept that led to the recognition of Factors V, VII, and X", and with Miss Nance, internationally credited with
6370-515: The photography industry pioneer and philanthropist Thomas Baker and his wife, Alice and sister-in-law, Eleanor Shaw, to assume financial responsibility. They decided the Institute should not only provide a better laboratory service for the hospital but should also have facilities for medical research. In 1926, prior to appointing its first director, the Baker Institute hired Australian bacteriologist and biochemist Phyllis Ashworth as its first biochemist and electrocardiographer . Ashworth worked with
6461-542: The prevention and treatment of cardiovascular disease, diabetes, obesity and their complications, such as kidney disease. In January 2016, Professor Thomas Marwick was appointed Director of the Institute. Professor Thomas Marwick FACC FESC FRCP FRACP had been Director of the Menzies Institute for Medical Research at the University of Tasmania and a Cardiologist at the Royal Hobart Hospital. He holds an MBBS from
6552-411: The profound health disadvantage experienced by Aboriginal Australians and Torres Strait Islanders. Jennings also oversaw one of the most significant changes in the institute's history, the merger in 2008 of the Baker Heart Research Institute with the International Diabetes Institute, which was founded and led by Zimmet. This created Australia's first multidisciplinary medical research institute dedicated to
6643-677: The recession, biomedical research spending decreased 2% in real terms in 2008. Despite an overall increase of investment in biomedical research, there has been stagnation, and in some areas a marked decline in the number of drug and device approvals over the same time period. As of 2010, industry sponsored research accounts for 58% of expenditures, NIH for 27% of expenditures, state governments for 5% of expenditures, non NIH-federal sources for 5% of expenditures and not-for-profit entities accounted for 4% of support. Federally funded biomedical research expenditures increased nominally, 0.7% (adjusted for inflation), from 2003 to 2007. Previous reports showed
6734-567: The resources and positions that are required to conduct science. The competition seems to suppress the creativity, cooperation, risk-taking, and original thinking required to make fundamental discoveries. Other consequences of today's highly pressured environment for research appear to be a substantial number of research publications whose results cannot be replicated, and perverse incentives in research funding that encourage grantee institutions to grow without making sufficient investments in their own faculty and facilities. Other risky trends include
6825-467: The rise of diabetes worldwide, providing new insights into the genetic and environmental determinants of type 2 diabetes. Professor John Funder AC was appointed Director in 1990 and bought his work on cardiovascular endocrinology, especially aldosterone action to the institute. Funder rewrote the pathophysiology of adrenal steroid action in the cardiovascular system, reshaping what we believe about aldosterone, cortisol and mineralcorticol receptors. He
6916-506: The science of diseases and the need to apply the advancing knowledge of biological science to human illness…” After convincing Baker to donate funds, firstly to the Alfred Hospital and then for research, he went on to become one of the founding Trustees of the Baker Medical Research Institute. Mackeddie recruited A. B. (Basil) Corkill as a biochemist for the new Institute. The salary was paid by Thomas Baker. The only consistent basic research in relation to diabetes and carbohydrate metabolism in
7007-495: The start of what is considered the "doubling period" of rapid NIH support. The second notable period started in 1997 and ended in 2010, a period where the NIH moved to organize research spending for engagement with the scientific community. Since 1980 the share of biomedical research funding from industry sources has grown from 32% to 62%, which has resulted in the development of numerous life-saving medical advances. The relationship between industry and government-funded research in
7098-572: The support of the Baker Institute, paving the way for Australia's first successful open heart operation at The Alfred Hospital in 1957 which was undertaken by Kenneth Morris. Morris went on to make major contributions to cardiac and thoracic surgery, alongside George Stirling (Director of the Cardiothoracic Surgery Unit at The Alfred Hospital from 1971 to 1988), with strong support from the Baker Institute in trialling and developing new cardiothoracic techniques. Professor Paul Korner AO ,
7189-420: The technology. Both government and industry research funding increased rapidly from between the years of 1994–2003; industry saw a compound average annual growth rate of 8.1% a year and slowed only slightly to a compound average annual growth rate of 5.8% from 2003 to 2008. " Conflict of interest " in the field of medical research has been defined as "a set of conditions in which professional judgment concerning
7280-504: The theoretical basis for the development of a revolutionary treatment of high blood pressure, involving silencing these nerves with a radio wave emitting catheter placed in the kidney arteries. This treatment, called Renal Sympathetic Denervation , is now used clinically in Europe and Australia for severe drug-resistant hypertension, and is in Stage 3 trials in the United States. He is the father of actor Ben Esler . Professor Esler has received
7371-501: The therapy is medically necessary or superior to cheaper treatments. For example, proton therapy was approved by the FDA, but private health insurers in the United States considered it unproven or unnecessary given its high cost, although it was ultimately covered for certain cancers. Fields of biomedical research include: Murray Esler Professor Murray David Esler , AM FAA (born in 1943 in Geelong , Australia )
7462-466: The work of the Baker Institute to have “..always been in the interface between scientific medicine and the practice of medicine, a field engendered and enhanced by its association with Alfred Hospital". They remark that from its earliest days, the staff were involved in communicating the outputs of research to the clinical community and the community in general. An example being the statewide tours of Victoria that Basil Corkill and Ewen Downe made to introduce
7553-435: The work requires no ethical approval, is supervised by scientists rather than physicians , and is carried out in a university or company, rather than a hospital. Clinical research is carried out with people as the experimental subjects . It is generally supervised by physicians and conducted by nurses in a medical setting, such as a hospital or research clinic, and requires ethical approval. Besides being participants in
7644-417: The world to date and claims responsibility for numerous innovations that have improved global health. The historical funding of biomedical research has undergone many changes over the past century. Innovations such as the polio vaccine, antibiotics and antipsychotic agents, developed in the early years of the NIH lead to social and political support of the agency. Political initiatives in the early 1990s lead to
7735-566: Was cardiology. At the time, it represented two-thirds of the total research in the Baker Medical Research Institute. Cardiology research included: The International Diabetes Institute was started in Melbourne in 1984 by Professor Paul Zimmet AO a number of years after his appointment to the Royal Southern Memorial Hospital. "The research of Paul and his team in Pacific and Indian Ocean populations has provided new insights into
7826-467: Was created to support and regulate this curiosity. In 1945, Vannevar Bush said that biomedical scientific research was "the pacemaker of technological progress", an idea which contributed to the initiative to found the National Institutes of Health (NIH) in 1948, a historical benchmark that marked the beginning of a near century substantial investment in biomedical research. The NIH provides more financial support for medical research than any other agency in
7917-612: Was formally created in 1930 under the McNarey Mapes Amendment to oversee the regulation of Food and Drugs in the United States. In 1962 the Kefauver-Harris Amendments to the Food, Drug and Cosmetics Act made it so that before a drug was marketed in the United States the FDA must first approve that the drug was safe. The Kefauver-Harris amendments also mandated that more stringent clinical trials must be performed before
8008-644: Was greater than the savings recognized by consumers no longer purchasing ineffective drugs. In 1984 the Hatch-Waxman Act or the Drug Price Competition and Patent Term Restoration Act of 1984 was passed by congress. The Hatch-Waxman Act was passed with the idea that giving brand manufacturers the ability to extend their patent by an additional 5 years would create greater incentives for innovation and private sector funding for investment. The relationship that exists with industry funded biomedical research
8099-424: Was intended to determine if a diet of vegetables and water was healthier than a diet of wine and red meat. At the experiment endpoint, the trial accomplished its prerogative: the youths who ate only beans and water were noticeably healthier. Scientific curiosity to understand health outcomes from varying treatments has been present for centuries, but it was not until the mid-19th century when an organizational platform
8190-430: Was recognised for his contributions to public policy across primary health issues. In 2001, cardiologist-researcher Professor Garry Jennings AO became the institute's sixth director. Under Jennings' leadership, the Institute grew substantially and by 2002, the Institute had its own purpose-built facilities adjacent to The Alfred Hospital. By 2007, a national Aboriginal Health research program was established to help address
8281-680: Was the Director of the Cardiovascular Clinical Research Facility at Leeds Teaching Hospitals NHS Trust in the United Kingdom and President of the British Cardiovascular Society. J. F. Mackeddie, a pathologist originally from Scotland, but who practised in Melbourne in the early 20th century, became a close friend of Thomas Baker through being neighbours on land south of the city. Mackeddie was "concerned with
#907092